MUKKAFast Moving Consumer Goods

Mukka Proteins Limited

Animal Feed · ISIN INE0CG401037 · BSE 544135 · NSE BE · FV ₹1
Last price
₹28
-4.23%today
What this company does

Mukka Proteins Limited operates in Animal Feed, part of the Fast Moving Consumer Goods sector. It booked ₹490 cr of revenue in its latest quarter (Q1 FY27) and kept 3.9% of sales as profit. It is the 3rd largest of 4 Animal Feed companies we track, by market value.

Their stated vision

to become a global leader in sustainable protein solutions, we have made strategic investments in technology, product development, and quality enhancement.

In the report:
43out of 100
Equitytale Health Score
Strained

Healthier than 43% of companies in Fast Moving Consumer Goods, on the 5 of 6 measures we could read for it. Each measure is ranked against the 36–149 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
52

At close. Not part of the score.

Profitability & returns69

How much profit it earns on the money it employs

Balance sheet18

How much it owes, and whether earnings cover the interest

Cash quality2

Whether reported profit actually arrives as cash

Valuation37

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Strengths
Makes a profit
Sales up 187% vs last year
Profit up 1,145% vs last year
Promoters hold 73%
No promoter shares pledged
Strong 15% return on equity
Watch-outs
! Thin 3.9% net margin
! Carries high debt (D/E 1.5)
! Operating cash flow is negative

What if I invest in MUKKA?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹28 -4.23%
latest close · 2026-09-17
52-wk low ₹2242 sessions so far52-wk high ₹33
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio11.2Low
LowAverageHigh
P/B ratio1.70Moderate
Below bookModerateHigh
EV / EBITDA8.1Average
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity15.1%Strong
WeakFairStrong ▸15%
Return on capital31.3%Strong
WeakFairStrong
Net margin3.9%Thin
ThinDecentStrong
EBITDA margin10.1%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity1.45High
LowModerateHigh ▸1
Interest cover2.7×Okay
RiskyOkayStrong ▸5×
Current ratio1.23Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹848 cr
Book value
₹17
EPS
₹0.63
latest quarter
Net debt
₹755 cr
owes more than its cash
Enterprise value
₹1,603 cr
EBITDA
₹198 cr
annualised
EBIT
₹179 cr
annualised
Operating margin
9.1%
Return on assets
4.7%
Earnings yield
8.91%
P/S
0.43
Sales / share
₹65.3
Tax rate
30.9%
Face value
₹1
Shares
30.0 cr
Working capital
₹240 cr
Current assets
₹1,289 cr
Current liabilities
₹1,049 cr
Delivery %
48.8%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2025 report & filings
not investment advice
Looks overpricedMedium confidence
Median of 3 models ₹15 vs market price ₹28 — price is 91% above it
Safety cushion-91.3%(target ≥ +20%)
Models span ₹12₹25, midpoint ₹15
Model ₹15
Price ₹28
Cheap sideExpensive side

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹490 cr
Other Income₹2 cr
Total Income₹491 cr
Cost of Materials₹392 cr
Purchases of Stock-in-Trade₹0 cr
Inventory Change (±)₹-10 cr
Employee Benefit Expense₹16 cr
Finance Costs₹16 cr
Depreciation & Amortisation₹5 cr
Other Expenses₹43 cr
Total Expenses₹463 cr
Profit before Tax₹28 cr
Tax Expense₹9 cr
Share of JV / Associates₹-95.1 L
Net Profit₹19 cr
Net margin on total income3.8%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹382 cr77.9%
Employee benefit expense₹16 cr3.3%
Finance costs₹16 cr3.4%
Depreciation & amortisation₹5 cr1.0%
Other expenses₹43 cr8.9%
Tax expense₹9 cr1.8%
Profit for the period₹19 cr3.8%
Total income ₹491 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue653 cr381 cr490 cr
Total income658 cr396 cr491 cr
Expenses627 cr367 cr463 cr
Profit before tax32 cr29 cr28 cr
Tax7 cr8 cr9 cr
Net profit (owners' share)24 cr21 cr19 cr
Net margin (owners' share, on revenue)3.6%5.4%3.9%
EPS (₹)0.790.690.63
YoY (latest quarter): total income +183.4% · net profit +1,145.0%
Balance sheet & cash flow · as of Mar 2026
High debt
Total assets
₹1,621 cr
Shareholder equity
₹499 cr
parent shareholders
Total debt
₹768 cr
Cash
₹13 cr
Cash flow · H1 FY26
Operating
₹-85 cr
Investing
₹-46 cr
Financing
₹135 cr
Peer comparison
Animal Feed · by market value
CompanyPriceMarket capP/E
Godrej Agrovet Limited₹654₹12,573 cr23.4
Avanti Feeds Limited₹771₹10,503 cr25.4
Mukka Proteins Limitedthis company₹28₹848 cr11.2
Narmada Agrobase Limited₹14₹53 cr17.3
Same industry · latest reported numbers · not a recommendation.
Who owns it · 2026-06-30
No pledge
Promoter
73.3%
FII / Foreign
1.7%
DII / Domestic
Retail / others
24.9%
Smart-money activity
Bulk / block deals
BoughtYUGA STOCKS AND COMMODITIES PRIVATE LIMITED . · NSE19.85 L @ ₹56.0616 Jul 24
SoldYUGA STOCKS AND COMMODITIES PRIVATE LIMITED . · NSE19.85 L @ ₹54.0616 Jul 24
SoldNK SECURITIES RESEARCH PRIVATE LIMITED · NSE24.07 L @ ₹53.6216 Jul 24
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 10 Sep 2026
See the official result
1
To receive, consider and adopt the Audited Standalone Financial statements of the Company for the Financial Year ended 31st March 2026, together with the reports of the Auditors and Board of Directors thereon and the Audited Consolidated Financial statements of the Company for the Financial Year ended 31st March 2026 and together with the report of the Auditors thereon.
Backed by 96% of shareholders other than promotersneeded 50%
6.45 L votes for, 24,717 against · 0% of mutual funds and other big investors said no
2
To appoint a Director in place of Mr. Kalandan Mohammad Arif (DIN: 03020564), who retires by rotation and being eligible offers himself for re-appointment.
Backed by 96% of shareholders other than promotersneeded 50%
6.44 L votes for, 26,200 against · 0% of mutual funds and other big investors said no
3
To appoint a Director in place of Mrs. Umaiyya Banu (DIN: 03051040), who retires by rotation and being eligible offers herself for re-appointment.
Backed by 96% of shareholders other than promotersneeded 50%
6.45 L votes for, 25,042 against · 0% of mutual funds and other big investors said no
4
To approve increase in overall borrowing limit of the Company under section 180(1)(c) of the Companies Act, 2013
Backed by 96% of shareholders other than promotersneeded 75%
6.43 L votes for, 26,597 against · 0% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 58 named members
owning 73.3% between them · as of 2026-06-30
MOHAMMED HARIS K30.23%
K MOHAMMAD ARIF16.13%
K MOHAMMED ALTHAF16.13%
KALANDAN ABDUL RAZAK7.33%
UMAIYYA BANU3.50%
Abdul Rahim Thayal Valappil Mammunhino shares
Acaya Exims Private Limitedno shares
Ainy Mariyam Harisno shares
Business done with them
FY2025 · 2 of the group
The company paid ₹2.6 L to companies in the promoter group last year — about 0.0% of its ₹1,006 cr revenue.
KALANDAN ABDUL RAZAK
Other payments to them · SITTING FEES, RENT AND RENT DEPOSITS GIVEN
also owns 7.33% of the company
₹1.6 L
company paid
UMAIYYA BANU
Other payments to them · SITTING FEES
also owns 3.50% of the company
₹1.1 L
company paid
KALANDAN ABDUL RAZAK
Leases As Lessee · SITTING FEES, RENT AND RENT DEPOSITS GIVEN
also owns 7.33% of the company
₹0.77 L
company received

The company also transacted with 22 other related parties — subsidiaries, joint ventures, directors and others — that we could not match by name to the promoter list above. Some may still be connected to the family; we only count the ones the filings let us match with certainty.

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.